Immediate Impact

47 standout
Sub-graph 1 of 19

Citing Papers

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
4 intermediate papers

Works of Donatella Grasso being referenced

Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study
2017
Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study
2015

Author Peers

Author Last Decade Papers Cites
Donatella Grasso 104 24 29 38 22 156
Yuriko N. Koyanagi 84 21 51 23 18 165
Konstantinos Christofyllakis 63 21 8 29 26 138
Gianmarco Leone 80 24 28 94 20 181
Andreas Jakob 90 24 13 71 20 169
Jamal Misleh 91 14 25 63 22 197
Marco Schupp 87 20 21 42 17 161
Kunal Jain 83 16 60 66 22 193
Philipp Berning 76 20 10 42 21 224
O. Scheibe 34 16 55 56 30 148
Cristina Morelli 117 36 49 50 23 186

All Works

Loading papers...

Rankless by CCL
2026